Stock data
Monopar Therapeutics Inc. (MNPR)
Monopar Therapeutics Inc. (MNPR) reported revenue of US$0.00M and net income of -US$13.72M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$0.00M | — | -US$16.70M | -US$13.72M | — |
| 2024 | US$0.00M | — | -US$16.16M | -US$15.59M | — |
| 2023 | US$0.00M | — | -US$8.83M | -US$8.40M | — |
| 2022 | — | — | -US$10.54M | -US$10.52M | — |
| 2021 | — | — | -US$9.13M | -US$9.10M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | — | -US$5.31M | — |
| 2026-03-31 | US$0.00M | -US$3.89M | — |
| 2025-12-31 | — | -US$5.20M | — |
| 2025-09-30 | — | -US$3.44M | — |
| 2025-06-30 | — | -US$2.45M | — |
| 2025-03-31 | — | -US$2.62M | — |
| 2024-12-31 | — | -US$10.93M | — |
| 2024-09-30 | — | -US$1.30M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.